1. OP0186 Tenofovir, a nucleoside analog reverse transcriptase inhibitor for treatment of hiv, promotes osteoclast differentiation and bone lost in vivo in a mechanism depending on atp release and adenosine, and dipyridamole may be a useful treatment to revert the effects. (15th June 2017) Authors: Conesa, FM; Llamas, P; Wilder, T; Atencio, P; Cabello, A; Gόrgolas, M; Cronstein, B; Largo, R; Herrero-Beaumont, G; Mediero, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗